Morning Headlines 4/7/17

23andMe, Inc. Granted First FDA Authorization to Market Direct-to-Consumer Genetic Health Risk Reports

More than three years after being shut down by the FDA for selling genetic health risk reports to consumers without clearance, 23andMe finally receives the FDA’s approval to resume sales. The approval covers reports on personal risk for ten conditions, including late-onset Alzheimer’s disease, Parkinson’s disease, and celiac disease.

Highly confidential psychotherapy records from Maine center listed on the dark web

A mental health center in Maine reports that 4,500 patient records have been stolen by hackers and offered for sale on the dark web. The records include highly-sensitive information, including names, addresses, social security numbers, medial histories, and full session notes.

SAFER Guides

ONC updates its SAFER Guides, a series of guides designed to help healthcare organizations address EHR safety issues.